Clinical trial
Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients…
NCT00083083 · American College of Radiology Imaging Network, Other · Unknown status
Key facts
| NCT number | NCT00083083 |
|---|---|
| Title | Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer |
| Official title | Positron Emission Tomography Pre- and Post-treatment Assessment For Locally Advanced Non-Small Cell Lung Carcinoma |
| Lead sponsor | American College of Radiology Imaging Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH Radiation Therapy Oncology Group |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Genetic, Procedure, Radiation |
| Interventions | carboplatin, cisplatin, docetaxel, etoposide, paclitaxel, vinblastine sulfate, vinorelbine tartrate, gene expression analysis, positron emission tomography, fludeoxyglucose F 18 and 1 more |
| Enrollment | 250 |
| Start date | Mar 1, 2005 |
| Primary completion | Jun 1, 2006 |
| First posted | May 17, 2004 |
| Last update posted | Mar 1, 2011 |
| Countries | Canada, South Korea, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: